Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
Hospital Ramón y Cajal
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Ramón y Cajal (7)
2023
-
Axillary staging and management of cN + breast cancer patients treated with neoadjuvant chemotherapy: results of a survey among breast cancer surgeons in Spain
Clinical and Translational Oncology, Vol. 25, Núm. 5, pp. 1463-1471
2022
2019
-
Breast implant-associated anaplastic large-cell lymphoma. Consensus document part II: Staging, prognosis and follow-up
Revista de Senologia y Patologia Mamaria, Vol. 32, Núm. 2, pp. 67-74
2018
-
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
EMBO Molecular Medicine, Vol. 10, Núm. 12
-
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
Annals of Oncology, Vol. 29, Núm. 5, pp. 1203-1210
2017
-
Role of total tumour load of sentinel lymph node on survival in early breast cancer patients
Breast, Vol. 33, pp. 8-13
2016
-
Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response
Annals of Surgical Oncology, Vol. 23, Núm. 12, pp. 3831-3837